Usnic Acid and Its Topical Use—A Concise Review
Molecules · 22.06.2026 · 31 (12) · 2183
DOI: 10.3390/molecules31122183 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 22.06.2026. Verfasst von Gabriela Siedlarczyk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, 16 Łazarza Str., 31-530 Cracow, Poland. Hauptthemen laut MEDLINE: Benzofurans. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Usnic acid (UA), a prominent lichen secondary metabolite, exhibits a unique dual therapeutic profile in dermatology, though its clinical translation is limited by systemic hepatotoxicity and poor solubility. This review comprehensively evaluates the topical efficacy, molecular mechanisms, and advanced formulation strategies of UA enantiomers and UA-rich extracts. A literature search across PubMed, Scopus, and Google Scholar identified 36 original publications focusing on anti-melanoma activity, photoprotection, and tissue regeneration. In vitro studies demonstrate that UA induces apoptosis in resistant melanoma cell lines (A375, HTB-140) via extrinsic/intrinsic pathways, with (−)-UA effectively overcoming doxorubicin resistance. Conversely, in non-cancerous models, low concentrations of UA accelerate wound and burn healing by upregulating vascular endothelial growth factor (VEGF), stimulating fibroblast proliferation, and optimizing extracellular matrix remodeling while preventing hypertrophic scarring. To mitigate skin sensitization and systemic risks, advanced drug delivery systems—including liposomes, nanoemulsions, chitosan nanogels, and electrospun scaffolds—have been developed, significantly enhancing skin permeability and localized dermal retention. Ultimately, the development of bio-functionalized smart dressings and targeted nano-formulations represents the most viable path toward unlocking the full clinical potential of UA in modern dermatological and oncological care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, 16 Łazarza Str., 31-530 Cracow, Poland.
- Department of Pharmacognosy, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.
ORCID-Profile: Irma Podolak, Agnieszka Galanty
Zitieren
APA
Siedlarczyk, G., Podolak, I., & Galanty, A. (2026). Usnic Acid and Its Topical Use—A Concise Review. Molecules, 31(12), 2183. https://doi.org/10.3390/molecules31122183
Vancouver
Siedlarczyk G, Podolak I, Galanty A. Usnic Acid and Its Topical Use—A Concise Review. Molecules. 2026;31(12):2183. doi:10.3390/molecules31122183
BibTeX
@article{Siedlarczyk2026,
author = {Siedlarczyk, Gabriela and Podolak, Irma and Galanty, Agnieszka},
title = {Usnic Acid and Its Topical Use—A Concise Review},
journal = {Molecules},
year = {2026},
volume = {31},
number = {12},
pages = {2183},
doi = {10.3390/molecules31122183}
}
EUVIMED